Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Kiniksa Pharmaceuticals, Ltd. (KNSA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/08/2023 |
SC 13G/A
| BlackRock Inc. reports a 4.9% stake in KINIKSA PHARMACEUTICALS LTD |
| 02/14/2023 |
SC 13G/A
| HHLR ADVISORS, LTD. reports a 7.6% stake in Kiniksa Pharmaceuticals, Ltd. |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.3% stake in Kiniksa Pharmaceuticals Ltd. Class A |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| AMERIPRISE FINANCIAL INC reports a 0% stake in Kiniksa Pharmaceuticals, Ltd |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.5% stake in Kiniksa Pharmaceuticals Ltd. Class A |
| 01/27/2022 |
SC 13G/A
| BlackRock Inc. reports a 10.3% stake in KINIKSA PHARMACEUTICALS LTD |
| 01/26/2022 |
SC 13G/A
| BlackRock Inc. reports a 10.3% stake in KINIKSA PHARMACEUTICALS LTD |
| 02/16/2021 |
SC 13G/A
| HILLHOUSE CAPITAL ADVISORS, LTD. reports a 9.2% stake in Kiniksa Pharmaceuticals, Ltd. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/05/2020 |
SC 13G/A
| Consonance Capital Management LP reports a 4% stake in Kiniksa Pharmaceuticals, Ltd. |
| 04/10/2020 |
SC 13G/A
| Arrowpoint Asset Management, LLC reports a 6.3% stake in Kiniksa Pharmaceuticals, Ltd. |
| 02/14/2020 |
SC 13G/A
| Hillhouse Capital Advisors, Ltd. reports a 9.9% stake in Kiniksa Pharmaceuticals, Ltd. |
| 02/13/2020 |
SC 13G/A
| Flynn James E reports a 0% stake in Kiniksa Pharmaceuticals, Ltd. |
| 02/12/2020 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.3% stake in Kiniksa Pharmaceuticals Ltd |
| 09/10/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|